GI
DPLO

Gradient Investments’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Gradient Investments’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-500
Closed -$2K – 1321
2019
Q4 		$2K Buy
+500
New +$2.35K ﹤0.01% 977

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Gradient Investments's DPLO Position: Q1 2020 in Review

Gradient Investments sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 500 shares — an estimated $2K sold.

Gradient Investments first reported a position in DPLO in Q4 2019 and held it in 1 quarter. The position peaked at $2K in Q4 2019. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Gradient Investments reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Gradient Investments sold 500 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $2K.
  • Gradient Investments first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2019 and held it in 1 quarter.
  • Gradient Investments's DIPLOMAT PHARMACY, INC. position peaked at $2K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Gradient Investments's 13F filing for Q1 2020, filed 7 Apr 2020.